TESLA & CureVac of Germany - Could It Be a Gamechanger?
Tesla, the world's top electric vehicle manufacturer, is working with a German biotech CureVac to develop a COVID-19 vaccine. CEO Elon Musk says, as a side project, he's building RNA microfactories for CureVac and possibly for other vaccine research groups. On Twitter, Musk has said synthetic RNA has "amazing potential" as an approach to immunizing patients against COVID-19.
CureVac is one of only 18 drug companies around the world with COVID-19 vaccine candidates in clinical testing. The company is working with so-called messenger mRNA, which deliver instructions from DNA to the body's protein makers - ribosomes. CureVac's approach is to customize mRNA to command ribosomes to make proteins that fight specific diseases like COVID or create antibodies to fight them. Several other drug companies including Moderna and Pfizer are taki…